They established an innovative Adeno-associated virus-mediated gene delivery system for these organoids, successfully creating a tauopathy model that develops tau protofibrils—a valuable tool for understanding tau pathology and developing targeted therapies [194]. The gene discussed is MAPT; the disease is tauopathy.